1
Department of Genetics, Research Institute of Biotechnology, Shahrekord University, Shahrekord, Iran
2
Department of Genetics and Molecular Biology; Pediatric Inherited Diseases Research Center; Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3
Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan, Iran
Emadi-Baygi,M. , Nikpour,P. and Emadi-Andani,E. (2015). SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis. Advanced Biomedical Research, 2015(july), 1-5.
MLA
Emadi-Baygi,M. , , Nikpour,P. , and Emadi-Andani,E. . "SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis", Advanced Biomedical Research, 2015, july, 2015, 1-5.
HARVARD
Emadi-Baygi M., Nikpour P., Emadi-Andani E. (2015). 'SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis', Advanced Biomedical Research, 2015(july), pp. 1-5.
CHICAGO
M. Emadi-Baygi, P. Nikpour and E. Emadi-Andani, "SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis," Advanced Biomedical Research, 2015 july (2015): 1-5,
VANCOUVER
Emadi-Baygi M., Nikpour P., Emadi-Andani E. SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis. Advanced Biomedical Research, 2015; 2015(july): 1-5.